Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23658454)

1.

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.

John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G, Smith SE, Elia AE, Everitt AR, Vora M, Pertel T, Elledge SJ, Kellam P, Brass AL.

J Virol. 2013 Jul;87(14):7837-52. doi: 10.1128/JVI.00481-13. Epub 2013 May 8.

2.

IFITM3 restricts the morbidity and mortality associated with influenza.

Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB; GenISIS Investigators; MOSAIC Investigators, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P.

Nature. 2012 Mar 25;484(7395):519-23. doi: 10.1038/nature10921.

3.

IFITMs restrict the replication of multiple pathogenic viruses.

Perreira JM, Chin CR, Feeley EM, Brass AL.

J Mol Biol. 2013 Dec 13;425(24):4937-55. doi: 10.1016/j.jmb.2013.09.024. Epub 2013 Sep 25. Review.

4.

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.

Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB.

PLoS Pathog. 2014 Apr 3;10(4):e1004048. doi: 10.1371/journal.ppat.1004048. eCollection 2014 Apr.

5.

S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Yount JS, Karssemeijer RA, Hang HC.

J Biol Chem. 2012 Jun 1;287(23):19631-41. doi: 10.1074/jbc.M112.362095. Epub 2012 Apr 17.

6.

IFITM3 polymorphism rs12252-C restricts influenza A viruses.

Williams DE, Wu WL, Grotefend CR, Radic V, Chung C, Chung YH, Farzan M, Huang IC.

PLoS One. 2014 Oct 14;9(10):e110096. doi: 10.1371/journal.pone.0110096. eCollection 2014.

7.

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL.

PLoS Pathog. 2011 Oct;7(10):e1002337. doi: 10.1371/journal.ppat.1002337. Epub 2011 Oct 27.

8.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

9.

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.

Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C.

J Virol. 2012 Dec;86(24):13697-707. doi: 10.1128/JVI.01828-12. Epub 2012 Oct 10.

10.

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Häcker H.

J Virol. 2014 Aug;88(16):9038-48. doi: 10.1128/JVI.00830-14. Epub 2014 Jun 4.

11.

Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.

Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, Kellam P, Fife M.

J Virol. 2013 Dec;87(23):12957-66. doi: 10.1128/JVI.01443-13. Epub 2013 Sep 25.

12.

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.

Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT.

J Virol. 2010 Dec;84(24):12646-57. doi: 10.1128/JVI.01328-10. Epub 2010 Oct 13.

13.

Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.

Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH.

J Biol Chem. 2013 Jun 14;288(24):17261-71. doi: 10.1074/jbc.M112.438515. Epub 2013 May 6.

14.

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.

Bailey CC, Zhong G, Huang IC, Farzan M.

Annu Rev Virol. 2014 Nov 1;1:261-283.

15.

Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation.

Shan Z, Han Q, Nie J, Cao X, Chen Z, Yin S, Gao Y, Lin F, Zhou X, Xu K, Fan H, Qian Z, Sun B, Zhong J, Li B, Tsun A.

J Biol Chem. 2013 Dec 6;288(49):35093-103. doi: 10.1074/jbc.M113.511949. Epub 2013 Oct 15.

16.

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.

Wrensch F, Winkler M, Pöhlmann S.

Viruses. 2014 Sep 26;6(9):3683-98. doi: 10.3390/v6093683.

17.

Ifitm3 limits the severity of acute influenza in mice.

Bailey CC, Huang IC, Kam C, Farzan M.

PLoS Pathog. 2012 Sep;8(9):e1002909. doi: 10.1371/journal.ppat.1002909. Epub 2012 Sep 6.

18.

Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.

Zhang W, Zhang L, Zan Y, Du N, Yang Y, Tien P.

J Gen Virol. 2015 Jan;96(Pt 1):170-82. doi: 10.1099/vir.0.066555-0. Epub 2014 Sep 16.

PMID:
25228491
19.

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.

Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, Aker AM, John SP, Sarlah D, Carreira EM, Elledge SJ, Kellam P, Brass AL.

Cell Rep. 2013 Nov 27;5(4):895-908. doi: 10.1016/j.celrep.2013.10.033. Epub 2013 Nov 21.

20.

The IFITM proteins inhibit HIV-1 infection.

Lu J, Pan Q, Rong L, He W, Liu SL, Liang C.

J Virol. 2011 Mar;85(5):2126-37. doi: 10.1128/JVI.01531-10. Epub 2010 Dec 22. Erratum in: J Virol. 2011 Apr;85(8):4043. He, Wei [added].

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk